Stock info Y-mAbs Therapeutics, Inc | Filter  Basic-Info

Stock: Y-mAbs Therapeutics, Inc (US broad)

Last Price 8.52 Max Price 15.69
Min Price 3.64 1 Year return 8.81
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USA

Sector Review Y-mAbs Therapeutics, Inc

Loading...
Year Turnover Total sector Market share
2019 0 136,070 0.00 %
2020 17 153,065 0.01 %
2021 31 227,669 0.01 %
2022 61 260,393 0.02 %
2023 77 215,054 0.04 %

Advice Y-mAbs Therapeutics, Inc

No Records Found



News Y-mAbs Therapeutics, Inc

No Records Found

Annual reports Y-mAbs Therapeutics, Inc

No Records Found

Profile Y-mAbs Therapeutics, Inc

No Records Found

Results Y-mAbs Therapeutics, Inc

Results
2021
2022
2023
2024
2025
Revenue
Costs
Profit
Margin of profit
ROI

Balance Y-mAbs Therapeutics, Inc

Balance
2021
2022
2023
2024
2025
Equity
Debt
Total assets
Solvency
Cash
Cashflow
Employees
Revenue per employee
Cashflow / Debt

Details Y-mAbs Therapeutics, Inc

Details
2016
2017
2018
2019
2020
Price
0.0
0.0
20.34
31.25
49.51
Eps
-0.50
-0.49
-1.31
-2.05
-2.44
Price/earnings-ratio
0.0
0.0
-15.53
-15.24
-3.49
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
0.35
2.10
3.58
4.47
2.13
Market to book
0.0
0.0
0.18
0.14
0.25
Cashflow per stock
-0.33
-0.41
-1.05
-1.65
-1.84
Stocks
33
33
34
40
41
Market Cap
0.00
0.00
695.50
1.241.51
346.67

Dividend Y-mAbs Therapeutics, Inc

Price info Y-mAbs Therapeutics, Inc

Date
Price
21 Aug 2025
8.52
15 Aug 2025
8.51
08 Aug 2025
8.51
07 Aug 2025
8.52
06 Aug 2025
8.52
05 Aug 2025
8.52
04 Aug 2025
4.19
01 Aug 2025
4.53
31 Jul 2025
4.47
30 Jul 2025
4.79
29 Jul 2025
4.97
28 Jul 2025
4.88
25 Jul 2025
4.77
24 Jul 2025
4.84
23 Jul 2025
4.81
22 Jul 2025
4.41
21 Jul 2025
4.33
18 Jul 2025
4.31
17 Jul 2025
4.32
16 Jul 2025
4.35
15 Jul 2025
4.22
14 Jul 2025
4.36
11 Jul 2025
4.36
10 Jul 2025
4.52
09 Jul 2025
4.44
08 Jul 2025
4.21
07 Jul 2025
4.22
03 Jul 2025
4.30
02 Jul 2025
4.26
01 Jul 2025
4.41
Overig aandelennieuws
Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
Y-mAbs Names Michael Rossi as President and Chief Executive Officer and Director
Y-mAbs Therapeutics Announces U.S. FDA Clearance of Investigational New Drug Application for CD38-SADA
Y-mAbs Announces Publication in Cancers
Y-mAbs Announces Data to be Presented at the 55th Congress of the International Society of Pediatric Oncology
Y-mAbs to Participate at Upcoming Investor Conferences in September
Analist
Returns European stocks
Crypto currencies information
About us Network Partners
Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2025 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo